Breadcrumb

CHAL  |  Cardiovascular Health across the Lifespan Program

Our Researchers

The Cardiovascular Health Across the Lifespan (CHAL) Program brings together seven basic researchers, thirty clinician-scientists and eight health outcomes researchers. Researchers from the Centre for Translational Biology (CTB) conduct basic research projects related to vascular function and related diseases, especially atherosclerosis, hypercholesterolemia and vascular injury. Investigators from the Centre for Innovative Medicine (CIM) focus their research on surgery outcomes and on improving prevention and care in patients affected by such cardiac diseases as heart failure, arrhythmias and valve diseases. Investigators from the Centre for Outcomes Research and Evaluation (CORE) seek to develop networks, databases and new tools to improve population health. These include epidemiological outcome and intervention studies on congenital heart disease (CHD), and different factors (genetic, environmental, gender-based) for cardiovascular diseases. CHAL researchers are based at the Glen site, at the heritage site of the Royal Victoria Hospital of the MUHC and at 5252 de Maisonneuve Boulevard W.

Filters icon icon

Displaying 13 result(s).

Michal Abrahamowicz, PhD

biostatistics

cohort studies

comparative effectiveness

confounding

instrumental variables

CORE

James Brophy, MD, PhD

cardiovascular epidemiology

pharmacoepideiology

Bayesian statistics

CORE

Natalie Dayan, MD, M.Sc., FRCPC

epidemiology

clinical research

women's health

pregnancy

maternal health

CORE

Mark Goldberg, B.Sc., M.Sc., PhD

epidemiology

environment

occupation

cancer

cardiorespiratory diseases

CORE

Isabelle Malhamé, MD, M.Sc., FRCPC

maternal health • severe maternal morbidity • severe cardiovascular morbidity • preeclampsia • severe hypertension • peripartum cardiomyopathy

CORE

Ariane Marelli, MD, MPH, FRCPC, FACC, FAHA

health services

epidemiology

congenital heart disease

cardiovascular

cardiology

CORE

Louise Pilote, MD, MPH, PhD, FRCPC

comparative effectivenesse

sex differences in cardiovascular diseases

outcomes research

cardiovascular epidemiology

pharmacoepidemiology

CORE

Marc Rodger, MD, M.Sc.

Venous thrombosis

pulmonary embolism

pregnancy

anticoagulation

diagnosis

CORE

Allan Sniderman, MD

prevention

cardiovascular

disease

atherosclerosis

apoB

CORE

Robyn Tamblyn, MScN, M.Sc., PhD, CM

health services

medical education

medical informatics

practice changes

pharmacoepidemiology

CORE

George Thanassoulis, MD

Genetics

genomics

cardiovascular disease

aortic stenosis

myocardial infarction

CORE

Explore what the CHAL Program has to offer